Sanofi SA To Buy US Drugmaker

France's Sanofi SA to buy US-based Principia Biopharma for $3.7 billion

The deal will strengthen Sanofi's research capabilities in areas such as autoimmune and allergic diseases, the companies said

Updated On: 18 Aug 2020 | 12:59 AM IST

Sanofi SA set to buy US drug maker Bioverativ for more than $11.5 bn: WSJ

Bioverativ, a hemophilia drug maker, was separated from Biogen Inc early last year

Updated On: 22 Jan 2018 | 8:51 PM IST